Ticker
AADI

Price
7.21
Stock movement down
-0.49 (-6.36%)
Company name
Aadi Bioscience Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Marknadsvärde
175.89M
Ent-värde
66.07M
Pris/omsättning
16.01
Pris/bok
1.04
Direktavkastning
-
Utdelningens tillväxt
-
Tillväxt år
-
FCF-utbetalning
-4.62%
Efterföljande P/E
-
Fremtidig P/E
-
PEG
-
EPS-tillväxt
-
1 års avkastning
-59.79%
3 års avkastning
-58.87%
5 års avkastning
-63.58%
10 års avkastning
-
Senast uppdaterad: 2023-03-22
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q4 2022 Earnings Conference Call March 28, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
28 mars 2023

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
28 mars 2023

iO Charts is a Seeking Alpha partner

UTDELNING

AADI Betalar inte utdelning
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
28 mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
27 mars 2023

iO Charts is a Seeking Alpha partner

UTVÄRDERING

Värderingsvillkor

Loading...
Data om värderingsgrad
Efterföljande P/E-
Pris till OCF-
Pris till FCF-
Pris till EBITDA-
EV i förhållande till EBITDA-

Värdering (Försäljning/Bokfört värde)

Loading...
Värderingsdata (försäljning/bokfört värde)
Pris till omsättning16.01
Pris till eget kapital1.04
EV i förhållande till försäljning6.01
Aadi Bioscience is a commercial stage company with a potential label expansion ahead. Click here to learn why I rate AADI stock a Buy.
7 mars 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
3 mars 2023

iO Charts is a Seeking Alpha partner

EKONOMI

Per aktie

Loading...
Data per aktie
Nuvarande aktiemängd24.40M
EPS (TTM)-2.94
FCF per aktie (TTM)-3.84

Resultaträkning

Loading...
Uppgifter om resultaträkningen
Intäkter (TTM)10.99M
Bruttovinst (TTM)10.00M
Rörelseintäkter (TTM)-63.16M
Nettoresultat (TTM)-62.59M
EPS (TTM)-2.94
EPS (1 år framåt)-2.53

Marginaler

Loading...
Marginer-data
Bruttomarginal (TTM)90.96%
Rörelsemarginal (TTM)-574.71%
Vinstmarginal (TTM)-569.57%

Balans

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om balansräkningen
Kontanter134.81M
Nettofordringar2.26M
Summa omsättningstillgångar189.86M
Goodwill0.00
Immateriella tillgångar0.00
Materiella anläggningstillgångar0.00
Summa tillgångar194.10M
Leverantörsskulder3.92M
Kortfristig/kortfristig långfristig skuld1.72M
Summa kortfristiga skulder17.89M
Summa skulder25.00M
Eget kapital169.11M
Materiella anläggningstillgångar netto169.11M

Kassaflöde

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om kassaflöde
Kassaflöde från den löpande verksamheten (TTM)-80.89M
Investeringar (TTM)676.00K
Fritt kassaflöde (TTM)-81.57M
Utbetald utdelning (TTM)3.77M

Finansiella intäkter

Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om finansiella intäkter
Avkastning på eget kapital-37.01%
Avkastning på tillgångar-32.25%
Avkastning på investerat kapital-36.93%
Kontantavkastning på investerat kapital-48.13%
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations &...
9 november 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
9 november 2022

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Uppgifter om aktiekurs
Öppning7.72
Dagens högsta7.72
Daglig låg7.20
Daglig volym120K
Den högsta någonsin1485.00
1 års analytikeruppskattning41.67
Beta-
EPS (TTM)-2.94
Utdelning per aktie-
Ex-div datum-
Nästa datum för resultatpresentation28 Mar 2023

Potential på nackdelen

Loading...
Negativa potentiella data
AADIS&P500
Nuvarande prisfall från toppnotering-99.51%-17.92%
Högsta prisfallet-99.51%-56.47%
Datum för högsta fall22 Mar 20239 Mar 2009
Genomsnittligt fall från topp-76.27%-11.51%
Genomsnittlig tid till ny topp72 days13 days
Maxtid till ny topp1337 days1805 days
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
8 november 2022

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
3 november 2022

iO Charts is a Seeking Alpha partner

UPPLYSNINGAR OM FÖRETAG
AADI (Aadi Bioscience Inc) company logo
Marknadsvärde
175.89M
Kategori av marknadsvärde
Small-cap
Beskrivning: __________
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Anställda
76
Investerarrelationer
-
SEC-inlämningar
Verkställande direktör
Land
USA
By
Typ av aktie
-
CCC-status
-
Utdelningsfrekvens
-
EVENEMANG OCH PRESENTATIONER
EvenemangPresentationer
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
12 oktober 2022

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
30 september 2022

iO Charts is a Seeking Alpha partner

FÖRSTÅ VERKSAMHETEN
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
22 september 2022

iO Charts is a Seeking Alpha partner

Aadi Bioscience shares lost half their value since reverse merger with Aerpio Pharmaceuticals. Click here to read why AADI stock is a Buy in my view.
21 september 2022

iO Charts is a Seeking Alpha partner

NYHETER OM FÖRETAGET
Alla nyheterPressmeddelanden
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, ...
28 mars 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
27 mars 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
26 mars 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
15 mars 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announce...
3 mars 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
22 februari 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
17 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, ...
9 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announce...
8 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
3 november 2022
Nästa sida
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - SVP of IR and Corporate CommunicationsNeil Desai -...
10 augusti 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
10 augusti 2022

iO Charts is a Seeking Alpha partner